Mogamulizumab

ATC L01FX09 · 8 markets · 10 records

Mogamulizumab 8 markets · 10 records Forms

AU 3 records · 3 strengths

20 mg/5 mLinjectionPOTELIGEO also in GB·SG
20 mginjectionPOTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion vial unknown

Records without a stated strength · 1 POTELIGEO

US 1 records · 1 strengths

4 mginjectionPOTELIGEO also in TW

GB 1 records · 1 strengths

20 mg/5 mLinjectionPoteligeo 20mg/5ml concentrate for solution for infusion vials also in AU·SG

CA 1 records · 1 strengths

4 mgliquidPOTELIGEO

SG 1 records · 1 strengths

20 mg/5 mLinjectionPOTELIGEO CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/5ML also in AU·GB

ES 1 records · 1 strengths

4 mg/1 mLinjectionPOTELIGEO

TW 1 records · 1 strengths

4 mginjectionPOTELIGEO 4 mg/mL concentrate for solution forinfusion+1波替立久濃縮靜脈輸注液 also in US

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 POTELIGEO

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	EU
20 mg/5 mL injection	not recorded	Poteligeo 20mg/5ml concentrate for solution for infusion vials	not recorded	POTELIGEO	POTELIGEO CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/5ML	not recorded	not recorded	not recorded
4 mg injection	POTELIGEO	not recorded	not recorded	not recorded	not recorded	not recorded	POTELIGEO 4 mg/mL concentrate for solution forinfusion 波替立久濃縮靜脈輸注液	not recorded
4 mg liquid	not recorded	not recorded	POTELIGEO	not recorded	not recorded	not recorded	not recorded	not recorded
20 mg injection	not recorded	not recorded	not recorded	POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion vial	not recorded	not recorded	not recorded	not recorded
4 mg/1 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	POTELIGEO	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	POTELIGEO	not recorded	not recorded	not recorded	POTELIGEO

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in CA · ES and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · ES que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · ES 有记录（未在本表显示）。另有 2 個規格/劑型僅在 CA · ES 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.